News | September 24, 2013

IBA Launches Visicoil Designed for Safer and Easier Implantation in Interventional Radiology

Visicoil fiducial marker is pre-loaded in 21 and 22 gauge thin needle to aid in percutaneous/transthoracic placement

September 24, 2013 — IBA (Ion Beam Applications S.A.) has launched an extension to the Visicoil product line at the annual ASTRO congress of the American Society for Radiation Oncology. This new design incorporates kV X-ray imaging compliant Visicoil Linear Markers pre-loaded in 21 and 22 gauge needles that are almost half the size of needles typically used for placement of gold seeds.

Compared to typical gold seeds, this new design enhances the ability of interventional radiology to safely and efficiently implant Visicoil markers, which subsequently supports radiation oncologists in highly precise patient setup and dose delivery during radiation therapy.

This new solution offers clinical benefits associated with smaller needles, such as increased patient safety and improved patient comfort. IBA’s patented Visicoil linear fiducial markers are an important component in the effort to increase targeting accuracy in radiation therapy applications such as stereotactic body radiation therapy (SBRT), image-guided radiation therapy (IGRT), intensity-modulated radiation therapy (IMRT), CyberKnife and proton therapy.

For more information:


Related Content

Insightec Announces Expanded Reach of MR-Guided Focused Ultrasound
News | Focused Ultrasound Therapy | August 22, 2017
Insightec announced recently that worldwide adoption of magnetic resonance (MR)-guided focused ultrasound continues to...
UCLA Study Offers Roadmap to Personalized Therapies for Sarcoma
News | Oncology Diagnostics | August 22, 2017
A new UCLA study is the first to identify patient and tumor characteristics that predict the successful creation of...
Sponsored Content | Videos | Information Technology | August 22, 2017
Melissa Martin, MS, president of the American Association of Physicists in Medicine (AAPM), discusses her vision of t
Sponsored Content | Videos | Proton Therapy | August 21, 2017
Mark Pankuch, Ph.D., director of medical physics at the Northwestern Medicine Chicago Proton Center, discusses the cl
Summit Cancer Center-Boise Treats First Cancer Patients With Accuray Radixact System
News | Image Guided Radiation Therapy (IGRT) | August 21, 2017
Accuray Inc. and the Summit Cancer Center-Boise announced that the center is now treating patients with the Radixact...
MedStar Georgetown Proton Center Selects RayStation for Treatment Planning
News | Treatment Planning | August 17, 2017
August 17, 2017 — The proton center at MedStar Georgetown University Hospital will utilize RayStation for planning on
DOSIsoft Releases ISOgray Proton Therapy Treatment Planning System
Technology | Treatment Planning | August 15, 2017
DOSIsoft SA announced the official release, with CE marking, of ISOgray Treatment Planning System (TPS) release 4.3 for...
First Radixact Results Presented at AAPM 2017
News | Radiation Therapy | August 10, 2017
Accuray Inc. announced that the first studies validating the benefits of the Radixact System were presented at the 59th...
Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
Overlay Init